Insider Transactions in Q4 2025 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
80,284
-50.52%
|
$6,663,572
$83.59 P/Share
|
|
Dec 24
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
145,000
+47.71%
|
$435,000
$3.88 P/Share
|
|
Dec 24
2025
|
Joseph K Belanoff Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
243,154
+7.63%
|
-
|
|
Dec 24
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
243,154
-100.0%
|
-
|
|
Dec 24
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
306,846
-55.79%
|
$25,468,218
$83.59 P/Share
|
|
Dec 24
2025
|
Joseph K Belanoff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
550,000
+50.0%
|
$1,650,000
$3.88 P/Share
|
|
Dec 12
2025
|
James N Wilson |
BUY
Other acquisition or disposition
|
Indirect |
400,000
+50.0%
|
-
|
|
Dec 12
2025
|
James N Wilson |
SELL
Bona fide gift
|
Indirect |
400,000
-27.68%
|
-
|
|
Dec 02
2025
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-62.65%
|
$1,600,000
$80.47 P/Share
|
|
Dec 02
2025
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+48.5%
|
$420,000
$21.65 P/Share
|
|
Dec 02
2025
|
William Guyer Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
787
+38.92%
|
-
|
|
Dec 02
2025
|
William Guyer Chief Development Officer |
SELL
Bona fide gift
|
Indirect |
787
-100.0%
|
-
|
|
Dec 02
2025
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-1.62%
|
$10,665
$79.78 P/Share
|
|
Dec 02
2025
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-1.03%
|
$8,690
$79.78 P/Share
|
|
Dec 02
2025
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
118
-0.8%
|
$9,322
$79.78 P/Share
|
|
Dec 02
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-1.05%
|
$11,692
$79.78 P/Share
|
|
Dec 01
2025
|
William Guyer Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
448
+41.67%
|
$17,472
$39.89 P/Share
|
|
Dec 01
2025
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
410
+2.44%
|
$15,990
$39.89 P/Share
|
|
Dec 01
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-71.67%
|
$1,580,000
$79.52 P/Share
|
|
Dec 01
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.75%
|
$160,000
$8.27 P/Share
|
|
Dec 01
2025
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
356
+1.66%
|
$13,884
$39.89 P/Share
|
|
Dec 01
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-32.73%
|
$395,000
$79.53 P/Share
|
|
Dec 01
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+24.66%
|
$65,000
$13.56 P/Share
|
|
Dec 01
2025
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
356
+1.21%
|
$13,884
$39.89 P/Share
|
|
Dec 01
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
448
+1.58%
|
$17,472
$39.89 P/Share
|
|
Dec 01
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.46%
|
$3,160,000
$79.77 P/Share
|
|
Nov 25
2025
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,500
-85.11%
|
$360,000
$80.9 P/Share
|
|
Nov 05
2025
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-33.81%
|
$1,500,000
$75.56 P/Share
|
|
Nov 05
2025
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+44.16%
|
$420,000
$21.65 P/Share
|
|
Nov 05
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
28,782
-0.35%
|
$2,158,650
$75.11 P/Share
|
|
Nov 03
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-71.67%
|
$1,460,000
$73.99 P/Share
|
|
Nov 03
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.75%
|
$160,000
$8.27 P/Share
|
|
Nov 03
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,218
-0.4%
|
$830,132
$74.08 P/Share
|
|
Nov 03
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-32.73%
|
$365,000
$73.65 P/Share
|
|
Nov 03
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+24.66%
|
$65,000
$13.56 P/Share
|
|
Oct 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$191,400
$87.54 P/Share
|
|
Oct 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$30,800
$14.08 P/Share
|
|
Oct 07
2025
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-79.09%
|
$1,780,000
$89.94 P/Share
|
|
Oct 07
2025
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+44.16%
|
$420,000
$21.65 P/Share
|
|
Oct 01
2025
|
Joseph K Belanoff Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.47%
|
$3,400,000
$85.04 P/Share
|
|
Oct 01
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-29.79%
|
$1,680,000
$84.79 P/Share
|
|
Oct 01
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+27.98%
|
$120,000
$6.66 P/Share
|
|
Oct 01
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-11.93%
|
$420,000
$84.67 P/Share
|
|
Oct 01
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+24.66%
|
$65,000
$13.56 P/Share
|